Evaluation of the Efficacy and Safety of the Lercanidipine (cas 100427-26-7)/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine (cas 100427-26-7) Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial
-
Add time:07/31/2019 Source:sciencedirect.com
PurposeThe objective of this study was to evaluate the efficacy and safety of the Lercanidipine (cas 100427-26-7)/valsartan combination compared with lercanidipine monotherapy in patients with hypertension.
We also recommend Trading Suppliers and Manufacturers of Lercanidipine (cas 100427-26-7). Pls Click Website Link as below: cas 100427-26-7 suppliers
Prev:Substituent effect of side chains on the photochemical behavior of a new generation 1,4-dihydropyridine: Lercanidipine (cas 100427-26-7)
Next:Synthesis, crystal and DFT studies of N-(carboxyethyl)-2-methylbenzothiazolium bromide) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Substituent effect of side chains on the photochemical behavior of a new generation 1,4-dihydropyridine: Lercanidipine (cas 100427-26-7)07/30/2019
- Neuroprotective effect of Lercanidipine (cas 100427-26-7) in middle cerebral artery occlusion model of stroke in rats07/29/2019
- Dissolution and bioavailability of Lercanidipine (cas 100427-26-7)–hydroxypropylmethyl cellulose nanoparticles with surfactant07/28/2019
-
Health and Chemical more >
-
Related Products